Bure Equity AB

Equities

BURE

SE0000195810

Investment Holding Companies

Market Closed - Nasdaq Stockholm 17:00:00 19/06/2024 BST 5-day change 1st Jan Change
358 SEK -1.49% Intraday chart for Bure Equity AB -5.74% +25.26%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Bure Equity AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Bure Equity AB Approves Ordinary Dividend for the 2023 Financial Year, Payable on 15 May 2024 CI
Bure Equity AB Proposes Ordinary Dividend for the 2023 Financial Year, Payable on 15 May 2024 CI
Bure Equity AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bure Equity AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Bure Equity AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
An Unknown buyer acquired 3.8% stake in Mycronic AB (OM:MYCR) from Bure Equity AB (OM:BURE) for SEK 870 million. CI
Bure Equity AB Announces Appointment of Nominating Committee CI
Yubico AB completed the acquisition of ACQ Bure AB (OM:ACQ SPAC) from a group of shareholders in a reverse merger transaction. CI
Bure Equity AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Vitrolife AB (publ) : A pioneer in in vitro fertilization Our Logo
Bure Equity AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bure Equity AB Approves Ordinary Cash Dividend, Payable on 10 May 2023 CI
Yubico AB agreed to acquire ACQ Bure AB (OM:ACQ SPAC) from a group of shareholders for SEK 8.2 billion in a reverse merger transaction. CI
Bure Equity AB Proposes Dividend for the Financial Year 2022, Payable on 10 May 2023 CI
Bure Equity AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Bure Equity AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Bure Equity AB Proposes Ordinary Dividend for 2022 CI
Bure Equity AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Bure Equity AB Announces Nominating Committee Appointments CI
Bure Equity AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Mentice AB announced that it has received SEK 60 million in funding from Bure Equity AB, AP Fonden 4, Handelsbanken Fonder AB, Teknik Innovation Norden Fonder AB CI
Bure Equity AB Approves Cash Dividend for the Year 2021 CI
Bure Equity AB Approves Appointment of Birgitta Stymne Göransson as Board Member CI
Bure Equity AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Chart Bure Equity AB
More charts
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. BURE Stock
  4. News Bure Equity AB
  5. Bure Equity : ACQ Bure Starts Trading in Stockholm, Becomes Scandinavia's First Listed SPAC